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Novel Patient-Centered Approach to Facilitate Same-Day Discharge in
Patients Undergoing Elective Percutaneous Coronary Intervention
Amit P. Amin, MD, MSc; Patricia Crimmins-Reda, RN, BSN; Samantha Miller, RN, BSN; Brandon Rahn, MHA; Mary Caruso, RN; Andrew
Pierce, MHSA; Brandy Dennis, RN Marissa Pendegraft, RN; Katrine Sorensen, MS; Howard I. Kurz, MD; John M. Lasala, MD, PhD; Alan
Zajarias, MD; Richard G. Bach, MD; Hemant Kulkarni, MD; Jasvindar Singh, MD
Background-—Same-day discharge (SDD) after elective percutaneous coronary intervention is safe, less costly, and preferred by
patients, but it is usually performed in low-risk patients, if at all. To increase the appropriate use of SDD in more complex patients,
we implemented a “patient-centered” protocol based on risk of complications at Barnes-Jewish Hospital.
Methods and Results-—Our objectives were as follows: (1) to evaluate time trends in SDD; (2) to compare (a) mortality, bleeding,
and acute kidney injury, (b) patient satisfaction, and (c) hospital costs by SDD versus no SDD (NSDD); and (3) to compare SDD
eligibility by our patient-centered approach versus Society for Cardiovascular Angiography and Interventions guidelines. Our
patient-centered approach was based on prospectively identifying personalized bleeding, mortality, and acute kidney injury risks,
with a personalized safe contrast limit and mitigating those risks. We analyzed Barnes-Jewish Hospital’s National Cardiovascular
Data Registry CathPCI Registry data from July 1, 2009 to September 30, 2015 (N=1752). SDD increased rapidly from 0% to 77%
(P<0.001), independent of radial access. Although SDD patients were comparable to NSDD patients, SDD was not associated with
adverse outcomes (0% mortality, 0% bleeds, and 0.4% acute kidney injury). Patient satisfaction was high with SDD. Propensity
score–adjusted costs were $7331 lower/SDD patient (P<0.001), saving an estimated $1.8 million annually. Only 16 patients (6.95%)
met the eligibility for SDD by Society for Cardiovascular Angiography and Interventions guidelines, implying our patient-centered
approach markedly increased SDD eligibility.
Conclusions-—With a patient-centered approach, SDD rapidly increased and was safe in 75% of patients undergoing elective
percutaneous coronary intervention, despite patient complexity. Patient satisfaction was high, and hospital costs were lower.
Patient-centered decision making to facilitate SDD is an important opportunity to improve the value of percutaneous coronary
intervention. ( J Am Heart Assoc. 2018;7:e005733. DOI: 10.1161/JAHA.117.005733.)
Key Words: cost • elective percutaneous coronary intervention • hospital costs • percutaneous coronary intervention • same-
day discharge • transradial • transradial approach
P ercutaneous coronary intervention (PCI) is a commoncardiovascular procedure, performed in >500 000
patients in the United States each year.1 Historically, overnight
observation after elective uncomplicated PCI was the standard
of care to monitor for periprocedural complications. This
practice of overnight observation has persisted despite marked
improvements in PCI, including the use of improved stent
design, uptake of radial access, reduction in bleeding compli-
cations, and newer and safer anticoagulation strategies.
Numerous single-center observational studies, small ran-
domized controlled trials, and meta-analyses have demon-
strated low complications, low cost, and higher patient
satisfaction with same-day discharge (SDD) after PCI in
carefully selected patients. However, what deﬁnes “carefully
selected” elective PCI patients has been inconsistently
applied, if deﬁned at all.2–9 Some studies have cau-
tiously explored the feasibility of SDD beyond the low-risk
population,7,10–14 but they were evaluated in selected patients
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or required protocols or checklists. To the best of our
knowledge, there are no studies that evaluate SDD in a
broader and higher-risk elective PCI population using an
explicit quantiﬁcation of patient-speciﬁc risks.
Performing SDD in higher-risk, more complex patients
requires a more explicit understanding and quantiﬁcation of
patients’ individualized risks for PCI complications. Patient-
centered decision making is deﬁned as “the process of
identifying clinically relevant, patient-speciﬁc circumstances
and behaviors to formulate a contextually appropriate care
plan.”15 With patient-centered decision making, higher-risk and
more complex patients could be considered for SDD provided
that the risks are recognized upfront and successfully
mitigated, which has never been reported. Although the
SOCRATES (Study of Costs Realized After Percutaneous
Coronary Intervention Employing Same Day Discharge) ran-
domized trial, NCT02207270 was designed to apply a patient-
centered approach to SDD, it was prematurely terminated
because of lack of enrollment.16 Furthermore, the cost and
patient satisfaction of SDD via a patient-centered approach
from a US hospital perspective have not been examined, which
is a growing area of concern as bundled payments emerge.
To enable SDD in higher-risk patients, we devised a novel
patient-centered protocol for SDD and implemented it at
Barnes-Jewish Hospital (BJH); St Louis, MO. Our objectives
were as follows: (1) to evaluate a trend in SDD over time;
(2) to compare patients undergoing elective PCI who did or did
not undergo SDD with respect to (a) patient and procedural
characteristics, (b) outcomes of mortality, bleeding, and acute
kidney injury (AKI), (c) patient satisfaction, and (d) costs of
hospitalization (direct variable cost, direct ﬁxed cost, and total
cost); and (3) to compare eligibility for SDD by our patient-
centered approach versus the established SDD recommen-
dations by the Society for Cardiovascular Angiography and
Interventions (SCAI) consensus statement.17
Methods
Patient-Centered SDD Protocol
Patient-centered care is the provision of care that is individ-
ualized and responsive to individual patient characteristics and
needs.15 We developed and implemented a decision aid using a
patient-centered care framework to facilitate SDD after
PCI.15,18 The patient-centered SDD program at BJH required
prospectively identifying risks of bleeding,19 mortality,20 and
AKI,21 with a patient-speciﬁc determination of a safe contrast
limit22 at the point of care, before PCI. We used the American
College of Cardiology’s NCDR (National Cardiovascular Data
Registry) CathPCI Registry models to identify the risks of
bleeding, mortality, and AKI19–21 and developed a method for
estimating the safe contrast limits.22 These were implemented
using the ePRISM (Health Outcomes Sciences, Kansas City, KS)
clinical decision aid that provided each patient’s individual risks
before the procedure (Figure 1).23 Risks were prospectively
reviewed by the interventional cardiologist performing the
procedure (A.A., H.K., J.S., J.L., R.B., A.Z.) before the procedure
in the catheterization laboratory holding area (Figure 2) to
deﬁne the appropriate risk mitigation strategies, including both
bleeding avoidance strategies24 and contrast limits22 (Fig-
ure 2). After the procedure, the interventionalist and a
catheterization laboratory holding area nurse ascertained
procedural success, if the risks were successfully mitigated,
and if the patient was stable after the procedure. The ﬁndings
were reviewed with the patient and family members and, if
everyone agreed, the patient was discharged the same day
even if the patient had undergone a complex PCI or had
numerous comorbidities (Figure 2). Thus, our protocol maxi-
mized patient centeredness at the point of care, and we
structured the intervention so that it was reproducible and
Clinical Perspective
What Is New?
• Same-day discharge is safe, less costly, and preferred by
patients, but it is usually performed in low-risk patients, if at all.
• By implementing a patient-centered protocol based on risk
of complications at Barnes-Jewish Hospital, we rapidly
increased same-day discharge from 0% to 77%, even in more
complex patients, with no increase in adverse outcomes,
high patient satisfaction, and lower costs of $7000/same-
day discharge patient, reducing hospital costs by an
estimated $1.8 million annually.
What Are the Clinical Implications?
• When risks of complications were proactively identiﬁed and
mitigated by a patient-centered approach at Barnes-Jewish
Hospital, complications were avoided and same-day dis-
charge became feasible in most patient undergoing elective
percutaneous coronary intervention.
• This resulted in not only high patient satisfaction but a large
reduction in hospital costs.
• We believe that our study has identiﬁed an important
opportunity to improve the value of percutaneous coronary
intervention for patients undergoing elective percutaneous
coronary intervention in the United States.
• Our approach represents an important initial step towards
achieving the triple aim of health care in percutaneous coronary
intervention: improving the patient experience, achieving
improved or equivalent outcomes, and lowering costs.
• Such strategies are essential as health care transitions from a
volume-based reimbursement paradigm to one focused on value.
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scalable. The protocol was implemented at the beginning of
quarter 4, 2013.
Study Population
For this study, we included elective PCIs performed at BJH
from July 1, 2009 to September 30, 2015 (N=1752). Elective
PCI is deﬁned in the NCDR CathPCI Registry as “the (PCI)
procedure performed on an outpatient basis without signiﬁ-
cant risk of infarction or death.” Because the protocol was
implemented in quarter 4 of 2013, we had ~3.5 years of pre-
intervention control data and 2 years of post-implementation
data. All variables in the data set were coded according to the
American College of Cardiology’s NCDR CathPCI Registry
Figure 1. Decision aid for patient-centered PCI care, which is reviewed by the interventionalist before percutaneous coronary intervention.
AKI indicates acute kidney injury; AUC, appropriate use criteria; GFR, glomerular ﬁltration rate; NCDR, National Cardiovascular Data Registry;
PCI, percutaneous coronary intervention; pLAD, proximal left anterior descending coronary artery; and 30DR, 30 day readmission.
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pdf).25 The ﬁnal cohort included for analyses was composed
of 1752 patients who underwent PCIs at BJH during the study
period. Of these patients, 230 (13%) underwent SDD during
the entire time period.
Predictors and Outcomes
The predictor variable of interest we examined was SDD (versus
NSDD, coded as 1 for patients who received an SDD and 0
otherwise). SDD was deﬁned as discharge occurring on the
same day of the PCI for elective PCI procedures performed on
an outpatient basis or for stable low-risk inpatients when the
date of hospital arrival and the date of PCI procedure was the
same as the date of discharge. This variable was either singly or
in combination with other covariates used in regression models
that permitted a comparison on the SDD and NSDD groups.
The primary outcomes of interest were outcomes of
bleeding, AKI, and death across the SDD groups. Bleeding was
deﬁned according to the NCDR CathPCI Registry deﬁnition as
any one of the following: (1) bleeding event within 72 hours,
(2) hemorrhagic stroke, (3) tamponade, (4) post-PCI transfu-
sion for patients with a preprocedure hemoglobin level >8 g/
dL and a preprocedure hemoglobin level not missing, or (5) an
absolute hemoglobin decrease from pre-PCI to post-PCI of
≥3 g/dL, preprocedure hemoglobin level <16 g/dL, and
preprocedure hemoglobin level not missing. AKI was deﬁned,
according to the Acute Kidney Injury Network criteria, as the
change from preprocedure to peak serum creatinine levels
≥0.3 mg/dL absolute increase or ≥1.5-fold relative increase
in serum creatinine. The secondary outcomes of interest were
patient satisfaction and cost. A postdischarge telephone
follow-up questionnaire was administered to patients by the
catheterization laboratory nurse (BD, MP) within the 2 days of
SDD to ascertain patient status, medication compliance,
access site problems, and patient satisfaction. This patient
satisfaction survey was available only in patients undergoing
SDD after November 1, 2014 (N=145), when we started this
assessment. The follow-up questionnaire consisted of the
following 11 questions:
1. How did you feel about being discharged the same
day?
2. Do you have any questions about your procedure?
3. Do you have any questions speciﬁc to your care?
4. Describe what your site looks like?
5. Were you able to obtain your prescriptions?
6. Were you able to take your medications?
7. Do you have a follow-up appointment with your cardiol-
ogist?
8. If no follow-up appointment, have you called to make an
appointment?
9. Do you have any problems or concerns after the proce-
dure?
10. Our goal is to provide you with the best care possible. How
would you rate your overall care?
11. Is there anyone you would like to mention or thank about
your care?
Of these 11 items, patient satisfaction with SDD was
ascertained via 2 nonvalidated questions, developed at BJH,
on a 5-point Likert scale:26
Figure 2. Overview of the patient-centered approach to same-day discharge (SDD) protocol. AKI indicates
acute kidney injury; BAS, bleeding avoidance strategies; OO, overnight observation; and PCI, percutaneous
coronary intervention.
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1. How did you feel about being discharged the same day?
2. Our goal is to provide you with the best care possible.
How would you rate your overall care?
Clinical variables were deﬁned by the NCDR CathPCI
Registry.25 Chronic kidney disease was deﬁned as a glomeru-
lar ﬁltration rate of ≤60 mL/min per 1.73 m2. An indicator
variable for complex PCI was created and deﬁned by the
presence of type C lesions, bifurcation lesions, bypass graft
lesions, lesions requiring atherectomy and chronic total
occlusion lesions. Atherectomy was deﬁned as use of a
Diamondback 360, or ELCA coronary LASER atherectomy
catheter, or Rotablator rotational atherectomy system.
Costs
Costs, from a hospital perspective, were directly obtained
from BJH’s ﬁnance department and linked to each speciﬁc
patient by his or her NCDR patient identiﬁer. We compared
mean values for 3 different hospital costs between SDD PCI
groups: direct variable cost, direct ﬁxed cost, and total cost.
Cost data were available for 63.69% of PCIs (n=1116). The
missing cost data were attributable to unavailability of cost
data from the BJH ﬁnance division for 2 years (2009, n=185
[10.55%]; and 2010, n=345 [19.69%]). Cost data were also
not available for the last few months of 2015 (n=94 [5.36%]).
From the other 4 years (2011, 2012, 2013, and 2014), cost
data were consecutively available and were missing only for
12 (0.68%) of patients. In aggregate, these accounted for
missing cost data for 636 patients (36.31%).
Direct variable costs were deﬁned as patient-speciﬁc
laboratory tests, medications, medical and surgical supplies,
and physician and nursing expenses. Direct variable costs were
composed of all medications, blood, disposable medical and
surgical supplies, devices, and implants obtained using a
microcosting approach from BJH’s ﬁnance department. Specif-
ically, the catheterization laboratory supply costs were
obtained from a registry of supply and costs and included
detailed balloons, wires, stents, other ancillary devices,
medications, and contrast costs. Physician and nursing
services were also included in direct variable costs. Direct
ﬁxed costs were independent of patient activity (eg, salaries of
other individuals involved in conducting PCI and equipment
maintenance costs). Direct ﬁxed costs were the departmental
ﬁxed staff salary and beneﬁts and equipment costs (accounting
for equipment depreciation). Indirect costs reﬂected the costs
incurred by the departments that did not produce revenue (eg,
information technology, plant maintenance, and hospital
ﬁnancial services) and were applied to all clinical departments
that generate revenue by the BJH ﬁnance department. Fixed
indirect costs were organizational administrative, housekeep-
ing, and facilities costs, including ﬁxed staff costs and
information technology costs (and their depreciation). These
costs were spread by multiple methods, depending on the
function of the department, including share of charges, square
footage, and department headcount. Total cost was the sum of
all direct variable, direct ﬁxed, and indirect costs.
Statistical Analysis
We ﬁrst described time trends in the proportion of patients
with SDD in each quarter to assess the discharge pattern
over time and tested the null hypothesis of no linear trend
with a 1-sided Cochran-Armitage test. Differences in the
patient and procedural characteristics between SDD groups
were described by means and percentages and tested with t
tests and the Pearson v2, as appropriate. We used box-and-
whisker plots and Mann-Whitney U tests to compare the
estimated risks of adverse outcomes across SDD groups. The
association of SDD with outcomes of bleeding, AKI, and
mortality was examined using the Fisher exact test. To
examine the association of the cost with SDD, we conducted
propensity score analyses and propensity adjustment. A
propensity score predicting SDD was generated (Figure 6). To
ensure that the propensity score was normally distributed
across the study groups, we used a logarithm-odds transfor-
mation of the raw propensity score. We assessed balance of
covariates with respect to SDD versus NSDD (Figure 6). To
estimate the adjusted cost associated with SDD, we used the
total costs as the dependent variable and SDD (coded as 1 or
0) and quintiles of the logarithm-odds propensity score as the
covariates in a least-squares linear regression model. Finally,
we applied the SDD criteria recommended in the 2009 SCAI
expert consensus statement17 to our “patient-centered” SDD
population, to examine the proportion of patients not meeting
SCAI criteria for SDD.
All results were tested for statistical signiﬁcance at a type I
error rate of 0.05. Analyses were performed using Stata 14.0
(Stat Corp, College Station, TX). The study was approved by
the Washington University institutional review board, and no
informed consent was required.
Results
Time Trends of SDD
SDD was rare in the 3.5 years before the personalized
protocol, occurring in only 0% to 4% of cases each quarter.
After implementation, there was a rapid increase in SDD
from 14% in the ﬁrst quarter to 78% in the last quarter
(Figure 3). The Cochran-Armitage trend test yielded a
statistically signiﬁcant 1-sided P<0.001, demonstrating a
signiﬁcant increasing time trend in the proportion of PCIs
with SDD. The rapidly increasing time trend in SDD
occurred independent of radial access; in the patients with
DOI: 10.1161/JAHA.117.005733 Journal of the American Heart Association 5






















femoral access, SDD increased from 1.06% in the third
quarter of 2009 to 69.23% in the third quarter of 2015,
implying that the patient-centered approach was perhaps
associated with rapidly increasing SDD in radial and femoral
patients alike.
Association of SDD With Patient and Procedural
Characteristics
In general, characteristics of the patients undergoing PCIs
who did or did not have SDD were largely comparable
(Table 1). However, those who underwent SDD were younger
(P<0.001) but had a signiﬁcantly higher prevalence of heart
failure (P<0.001), prior myocardial infarction (P=0.004), and
prior PCI (P<0.001) compared with the NSDD group (Table 1).
Procedural characteristics of the study groups are also shown
in Table 1. Mean total lesion length, mean number of
diseased vessels, and percentage of saphenous vein grafts
were nearly identical between SDD groups. The percentage of
PCIs with type C lesions (P=0.015), procedural access
through the radial artery (P<0.001), and vascular closure
devices among femoral PCIs (P<0.001) were higher in SDD
PCIs. Conversely, mean number of lesions (P<0.001), mean
number of stents (P<0.001), and percentage with atherec-
tomy (P<0.001) were higher in the NSDD group compared
with the SDD patients.
Figure 3. Percentage of percutaneous coronary interventions
(PCIs) with same-day discharge (SDD) over time. The bar chart
shows proportion of PCIs with SDD during each study quarter. The
Cochran-Armitage test for trend yielded a 1-sided P<0.001,
indicating a statistically signiﬁcant trend.







Age, meanSD, y 62.411.7 65.411.9 <0.001




Diabetes mellitus, N (%) 88 (38) 640 (42) 0.277
Dyslipidemia, N (%) 217 (94) 1380 (91) 0.067
Hypertension, N (%) 211 (92) 1386 (91) 0.737
Chronic lung disease,
N (%)




per 1.73 m2 N (%)
58 (25) 403 (26) 0.686








57 (25) 365 (24) 0.791
Prior cerebrovascular
disease, N (%)
41 (18) 253 (17) 0.649
Prior heart failure,
N (%)
108 (47) 411 (27) <0.001
Prior myocardial
infarction, N (%)
122 (53) 637 (42) 0.001
Prior peripheral vascular
disease, N (%)
45 (20) 238 (16) 0.131
Prior PCI, N (%) 154 (67) 740 (49) <0.001
Procedural characteristics




Type C lesion, N (%) 159 (69) 937 (62) 0.027
Bifurcation, N (%) 41 (18) 342 (22) 0.112
Chronic occlusion, N (%) 18 (8) 80 (5) 0.114
Atherectomy, N (%) 4 (2) 124 (8) 0.001
No. of diseased vessels,
meanSD
1.50.8 1.60.8 0.112
No. of stents, meanSD 1.50.8 1.91.1 <0.001
Radial access, N (%) 100 (42) 69 (5) <0.001
Closure proportion,
N (%)*
111 (85) 887 (61) <0.001
NSDD indicates no SDD; PCI, percutaneous coronary intervention; and SDD, same-day
discharge.
*Closure devices proportion is assessed for PCI with femoral access only (N = 1583); of
which SDD = 130; and NSDD = 1453.
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Association of SDD With Predicted Probability of
Mortality, Bleeding, and AKI
We prospectively performed preprocedural risk assessment for
adverse events of mortality, bleeding, and AKI. These predicted
probabilities of adverse outcomes are shown in Figure 4. When
compared using the Mann-Whitney test, we observed that the
median predicted probability of mortality and AKI was signif-
icantly higher in the SDD group, whereas the predicted
probability of bleeding was comparable in both groups.
Association of SDD With Outcomes of Mortality,
Bleeding, and AKI
From 2009 to 2015, a total of 4 deaths (0.2%), 16 bleeding
events (0.9%), 44 transfusion events (2.5%), and 41 AKI events
(2.3%) occurred (Table 2) in the study patients. Other adverse
events, including vascular complications, new-onset dialysis,
cerebrovascular attack, new-onset heart failure, and peripro-
cedural myocardial infarction, are also shown in Table 2.
Other than 1 AKI event, no other adverse outcomes occurred
in the SDD groups (Table 2). By the Fisher exact test, there
was no statistical difference in the outcomes of mortality,
bleeding, and AKI (all P=NS).
Patient Satisfaction
Although patient satisfaction was assessed in only 145 of the
230 SDD patients, they reported high satisfaction. We
obtained 145 responses to the question: “How did you feel
about being discharged the same day?”; of the patients, 144
(99.31%) reported feeling “extremely satisﬁed.” Among the
135 responses to the question: “Our goal is to provide you
with the best care possible. How would you rate your overall
care?”; of the patients, all 135 (100%) reported “excellent
care.” These questionnaires were not administered to the
NSDD group of patients.
Association of SDD With Hospital Costs
We ﬁrst compared the discharge practice and outcomes based
on whether cost data were available (cost data available group)
or not (cost data not available group). We observed that the
proportion who were discharged on the same day was 14% and
13% in the cost data available and cost data not available
groups, respectively, which was statistically not signiﬁcant
(P=0.548). For the outcomes also, the proportions of patients
with mortality (0.36% versus 0%; P=0.303), a bleeding event
(1.25% versus 0.31%; P=0.065), and AKI (2.87% versus 2.00%;
P=0.286) in the cost data available and cost data not available
groups, respectively, were comparable.
We found (Figure 5A) that the median values for all the
studied cost variables were signiﬁcantly lower for the SDD
group compared with the NSDD group, even when we used
nonparametric methods for testing of statistical signiﬁcance.
The mean total cost of PCI was $10 425.62$2305.77 for
the SDD group compared with $17 135.91$16 917.23 for
the NSDD group, a difference of $6710 favoring SDD. This
resulted in a cost savings of 39.15% (see the pie charts at the
top of Figure 5A. The cost savings attributable to SDD were
from 36.76% to 46.36%, indicating a substantial cost saving.
The greatest relative savings occurred in the direct ﬁxed costs
(Figure 5A), perhaps because of a reduction in use of ﬁxed
hospitalization resources related to a reduced length of stay.
Consistent with the temporal increase in the proportion of
SDD PCIs over time (shown in Figure 3), we also observed
that each percentage increase in a shift towards the SDD
strategy was associated with a 0.77% improvement in total
cost savings (P=0.0145; Figure 5B).
Propensity-Adjusted Cost Reduction Associated
With SDD
We ﬁrst developed a propensity score to account for confound-
ing by patient and procedural characteristics to predict the
likelihood of SDD. After adjusting the sequential logistic models
to account for these interactions, the propensity score
generating model contained all variables balanced across the
Figure 4. Box-and-whisker plots of preprocedure predicted
risks of mortality, bleeding, and acute kidney injury (AKI) by
same-day discharge (SDD) groups. A comparative diagram with 6
box-and-whisker plots grouped by risk type (mortality, bleeding, or
AKI) and SDD status (ﬁlled boxes, SDD; empty boxes, no SDD
[NSDD]). Predicted probability was a summary measure obtained
using the National Cardiovascular Data Registry method.19–21
Shown at the top are the median values for each box plot and P
value (obtained using Mann–Whitney test)
DOI: 10.1161/JAHA.117.005733 Journal of the American Heart Association 7






















study groups (compare the red dots with the blue dots in
Figure 6A). We observed that the raw propensity score was
heavily skewed (Figure 6B, left panel) across study groups and,
hence, we used the logarithm odds of this raw propensity score
as the ﬁnal propensity score (Figure 6B, right panel). This
logarithm odds score was clearly higher in the SDD patients
(mean, 0.49) compared with the NSDD patients (mean,
3.14; Figure 6C). After adjusting for quintiles of this propen-
sity score, we found that the adjusted per-patient cost
difference between the SDD and NSDD groups was $7331
(95% conﬁdence interval, $4370–$10 292). Using this
adjusted estimate of the reduced per-patient costs, we
estimate that even if the current rates of 75% SDDs for an
average of 250 elective PCIs every year continue, then the total
annual saved costs for BJH will be $1 843 233.
Comparison of SDD Eligibility by Patient-Centered
Approach Versus SCAI Criteria
When we applied criteria for SDD recommended in 2009 by
the SCAI expert consensus statement, we found that 1628 of
1752 patients (92.9%) at BJH were not eligible for SDD. These
noneligible patients had the following characteristics: estab-
lished congestive heart failure (N=673) or existing left
ventricular systolic dysfunction (N=158), chronic kidney
disease with an eGFR of ≤60 ml/min/1.73 m2 (N=187),
current dialysis (N=2), prior stroke, transient ischemic attack,
or cerebrovascular disease (N=94), peripheral vascular dis-
ease (N=58), chronic lung disease (N=79), use of glycoprotein
IIb/IIIa inhibitors (N=113), stent length ≥28 mm (N=204),
femoral access with no closure device (N=47), atherectomy
device used (N=4), left main or chronic total occlusion PCI
(N=8), and coronary perforation during PCI (N=1). No patients
would have been disqualiﬁed for coagulopathy, contrast
allergy, inadequate thienopyridine load, complications, and
poor at-home support. Of the 230 patients undergoing SDD in
our study, only 16 (6.96%) were eligible for SDD by the SCAI
expert consensus guideline, implying that the other 214
(93.04%) patients’ SDD was perhaps facilitated by our patient-
centered approach.
Discussion
This is the ﬁrst and only study, of which we are aware, to
examine patient-centered decision making through an explicit
risk-based protocol for facilitating SDD in patients undergoing
elective PCI. Our approach represents an important initial step
towards achieving the triple aim of health care in PCI:
improving the patient experience, achieving improved or
equivalent outcomes, and lowering costs.27 A patient-
centered framework explicitly uncovers a distinct cognitive
aspect in clinical decision making: the ability to classify
patient’ conditions into speciﬁc risk categories that then
Figure 5. Costs associated with SDD in elective PCI. (A) Distribution of various costs across SDD groups. The box plots show the distribution
of the color-coded buckets based on SDD status (ﬁlled boxes - SDD, empty boxes, NSDD). Signiﬁcance values were obtained using the Mann-
Whitney test. Pie charts at the top show the estimated cost saving (deﬁned as 100xper-patient cost difference/per-patient cost in the no-SDD
group). (B) Association of cost saving with proportion of SDD PCIs. These 2-year, quarterly data span from third quarter in 2013 up to 2nd quarter in
2015. Each dot represents a combination of the SDD rate (x axis) and estimated cost saving (y axis). Regression coefﬁcient was obtained using
ordinary least squares regression. Results of the regression analyses indicate that for every additional 10% SDD resorted to in a quarter the cost
savings increased by an additional 7.7%. NSDD indicates No SDD; PCI, percutaneous coronary intervention; and SDD, Same-day discharge.
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permits the application of evidence to individualize treatment
to risk. Such strategies are essential as health care transitions
from a volume-based reimbursement paradigm to one focused
on value.
The most compelling ﬁnding of this study is that our
patient-centered approach, with prospective risk stratiﬁcation,
led to a deliberate and planned risk mitigation strategy, one
that facilitated SDD in almost all patients in the last quarter
despite complex PCI and patient comorbidities. Indeed, in this
large, observational, single-center study, we found the patient
and procedural characteristics and the risk proﬁle from a
procedural perspective were largely similar between SDD and
NSDD groups. We found that the SDD approach was safe, and
adverse outcomes were not statistically different between
SDD and NSDD groups, although they were numerically lower
in the SDD group. The cost savings from SDD to the hospital
were large, ranging from 36% to 46% for various cost
categories. Most important, almost all the patients who were
sent home the same day reported excellent patient satisfac-
tion. From a physician perspective, it is noteworthy that when
we implemented the protocol in quarter 4 of 2013, PCI
operators did not feel comfortable discharging patients with
SDD immediately, but the personalized approach facilitated a
rapid increase in SDD over time. Finally, our patient-centered
approach facilitated SDD in >10-fold as many patients as
deﬁned by the SCAI expert consensus guideline.
There is an emerging body of literature7,12,14,28 suggesting
that SDD may be performed in more complex and elderly
patients undergoing PCI, in whom complex characteristics
alone are not sufﬁcient indicators for necessitating overnight
admission. Unfortunately, the existing SDD “criteria,”17 which
are applicable to a lower-risk population, are potentially too
conservative to be applied in an increasingly complex elective
PCI population treated in contemporary practice. As elective
PCI complexity and patient comorbidity further increase, a
risk-based approach is likely to be the best strategy for safely
guiding SDD decisions. Our approach allowed 3 of 4 patients
undergoing elective PCI to be discharged the same day,
despite having similar risk proﬁles to those who had
previously been in the NSDD group.
We observed that the median predicted probability of
mortality and AKI was signiﬁcantly higher in the SDD group
than in the NSDD group. When the patient-centered approach
to SDD was implemented prospectively, there was a careful
review of comorbidities and improved understanding of
patient-speciﬁc risks that, in turn, led to risk mitigation
strategies. We hypothesize that perhaps a careful assess-
ment of patient-speciﬁc risks led to a slightly numerically
higher predicted probability of mortality and AKI in the SDD
groups versus the NSDD group. This also partly explains why
the SDD group showed a younger age but a paradoxically
more complex pattern of cardiac comorbidities (Table 1).
Notably, these results do not imply that higher-risk patients
were being discharged irresponsibly; conversely, the results
show that these patients were probed carefully for all factors
before SDD. In aggregate, our ﬁndings indicate that the
intuitive clinical logic of withholding SDD in complex PCIs
may be overcome by using a patient-centered approach to
SDD.
Because PCI is the most common cardiovascular proce-
dure in the United States,1,29,30 it is also a major driver of








Mortality 0 (0) 4 (0.3) 1.000
Bleeding* 0 (0) 16 (1.1) 0.252
Acute kidney
injury†
1 (0.5) 40 (2.8) 0.080
Transfusion‡ 0 (0) 44 (2.9) 0.003
Other vascular
complications§
0 (0) 17 (1.1) 0.151
Dialysisk 0 (0) 0 (0) 1.000
Cerebrovascular
attack¶
0 (0) 0 (0) 1.000
Heart failure# 0 (0) 1 (0.1) 1.000
Myocardial
infarction**
0 (0) 54 (3.6) 0.001
NSDD indicates no SDD; and SDD, same-day discharge.
*Bleeding was deﬁned according to the National Cardiovascular Data Registry CathPCI
Registry deﬁnition as any one of the following: (1) bleeding event within 72 hours; (2)
hemorrhagic stroke; (3) tamponade; (4) post–percutaneous coronary intervention (PCI)
transfusion for patients with a preprocedure hemoglobin level >8 g/dL and
preprocedure hemoglobin level not missing; or (5) an absolute hemoglobin decrease
from pre-PCI to post-PCI of ≥3 g/dL, preprocedure hemoglobin level <16 g/dL, and
preprocedure hemoglobin level not missing.
†Acute kidney injury was deﬁned according to the Acute Kidney Injury Network criteria
as the change from preprocedure to peak serum creatinine levels ≥0.3 mg/dL absolute
increase or ≥1.5-fold relative increase in serum creatinine.
‡Transfusions were deﬁned as transfusion(s) of either whole blood or packed red blood
cells.
§Vascular complications were deﬁned as any other vascular complications (excluding
external bleeding or hematomas) at the percutaneous entry site that required treatment
or intervention, including, but not limited to, access site occlusions, peripheral
embolizations, dissections, pseudoaneurysms, and/or AV ﬁstulas. Any noted vascular
complication must have had an intervention, such as a ﬁbrin injection, angioplasty, or
surgical repair, to qualify. Prolonged pressure did not qualify as an intervention, but
ultrasonic-guided compression after making a diagnosis of pseudoaneurysm did qualify.
kNew onset of dialysis was deﬁned as present if the patient experienced acute or
worsening renal failure necessitating renal dialysis of all types, including continuous
venovenous hemoﬁltration, between start of procedure and until next procedure or
discharge.
¶A stroke or cerebrovascular accident was deﬁned as loss of any neurological function
caused by an ischemic or hemorrhagic event, with residual symptoms lasting at least
24 hours after onset or leading to death.
#New onset of heart failure was deﬁned as new onset or acute recurrence of heart
failure, which necessitated new or increased pharmacologic therapy.
**In patients with normal baseline (preprocedure) cardiac biomarker values, myocardial
infarction within 24 hours after percutaneous coronary intervention was deﬁned as
follows: Elevations of cardiac biomarkers >3 times the upper limit of normal for your
laboratory (ie, >3 times the 99th percentile upper reference limit for a normal
population). ECG changes or symptoms were not required to qualify.
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healthcare costs. PCI costs are expected to cost the United
States $918 million by 2030.31 Consequently, approaches
that reduce costs are urgently needed. Our study builds on
and extends an accumulating body of evidence showing that
SDD is safe and associated with lower costs of care. Two
recent meta-analyses of randomized controlled trials of SDD
have conﬁrmed the safety of SDD in terms of adverse events,
such as mortality, myocardial infarction, major bleeding, blood
transfusion, repeated revascularization, and rehospitalization;
these adverse events were not signiﬁcantly different between
SDD and overnight stay groups, up to 30 days after PCI.3,32 In
the current climate of healthcare reform, lower costs of care
offer a tremendous competitive advantage to hospitals. There
is a constant and increasing pressure on the US healthcare
system to reduce costs of care, and hospitals are increasingly
challenged to deliver higher-quality care at lower costs.27,33
Alternative payment models require that hospitals assume
both ﬁnancial and performance accountability for the care of
Figure 6. Propensity score analyses to estimate adjusted cost reductions associated with same-day
discharge (SDD). A, Development of the propensity score using a sequential variable, balancing strategy
implemented in the prop_sel package. The residual imbalance after adjustment is shown using red dots,
and the corresponding imbalance before adjustment is shown using blue dots. All variables had acceptable
levels of imbalance. B, Kernel density plots for the raw propensity score (left panel) and the logarithm (log)-
odds transformed propensity score (right panel) for the SDD and no SDD (NSDD) groups. C, Average log-
odds transformed propensity score across the study groups. The error bars represent 95% conﬁdence
intervals. BMI indicates body mass index; CABG, coronary artery bypass grafting; CVD, cardiovascular
disease; MI, myocardial infarction; PAD, peripheral artery disease; and PCI, percutaneous coronary
intervention.
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their patients undergoing PCI. Current and future healthcare
delivery models, such as bundled payments, will provide even
stronger incentives for hospitals to improve the efﬁciency of
the care they provide. In a large national study of >250 000
patients undergoing elective PCI who are eligible for SDD from
Medicare data, we previously found that the adjusted cost
associated with transradial access for PCI combined with SDD
was $13 389, whereas the cost associated with the tradi-
tional transfemoral access and overnight observation was
$17 076, a difference of $3689 (95% conﬁdence interval,
$3486–$3902; P<0.0001).34 A Canadian study by Rinfret
et al that compared SDD after transradial PCI with overnight
hospitalization realized a 50% reduction, or $1100 per
patient, in medical costs in Canada.35 Muthusamy et al, from
Spectrum Health (Grand Rapids, MI), found similar cost
savings when analyzing Spectrum Health’s ﬁrst 200 SDD
patients undergoing PCI.6 Our cost savings are higher in
magnitude than prior studies reporting cost savings in the
range of $1500 to $3600.34,36 However, these studies
involved a carefully selected and a lower-risk population,
and we hypothesize that when SDD is applied to a less
selective, “all-comer,” higher-risk population, then cost sav-
ings increase in magnitude.
We observed that the radial artery was accessed in 42% of
PCIs with SDD, compared with only 4.5% of PCIs without SDD
(Table 1). Previous studies have shown radial access to be
associated with many beneﬁts, such as reductions in bleeding
rates and major vascular complications.37–43 It is also the
patient-preferred arterial access site44,45 and associated with
lower cost.34,36 Concurrent with the increase in proportion of
SDD rates over time, we also observed a temporal increase in
the proportion of radially accessed PCIs (data not shown). For
example, in the ﬁrst quarter of 2013, the proportion of radial
PCIs was 7%, which increased to 30% in the third quarter of
2015. In concert, these observations imply a paradigmatic
shift from the past practice of femoral artery as the
predominant access site for PCI. Our ﬁndings support this
shift, showing that transradial PCIs may provide more
opportunities for SDD than the more prevalent transfemoral
access.
Despite the success of radial access, there are cases in
which the femoral artery remains the ideal procedural access.
It is important to recognize that, in our study, more than half
of the patients discharged the same day actually underwent
femoral access. We had a total of 1590 PCIs with femoral
access, 137 of which had SDD. SDD increased equally rapidly
in patients undergoing femoral PCI as in patients undergoing
radial PCI, implying that the patient-centered decision making
was perhaps instrumental in SDD, independent of radial
access. A signiﬁcant difference in the use of vascular closure
devices (VCDs) was present between SDD groups; almost all
PCIs with SDD had closure devices used (85%). The observed
reduced hospitalization of PCIs with VCDs is not particularly
surprising when considering its inﬂuence on shorter hemosta-
sis compared with manual compression.24 Our ﬁndings agree
with several prior studies that examined the safety of SDD
with femoral access and closure devices.46,47 Our study builds
on prior studies that a patient-centered approach and careful
preprocedural risk assessment enable a better informed and
cognizant approach to SDD despite femoral access. In our
observation, the explicit recognition and mitigation of proce-
dural risks facilitate SDD despite a femoral approach. In
addition, patient centered decision making engages patients
in a more clear understanding of risks and beneﬁts and
improves patient satisfaction.48
Limitations
Our ﬁndings need to be interpreted in the context of several
potential limitations, primarily imposed by the data. First, this
is a single-center study with a limited sample size and the
data included in this article may not be generalizable to other
hospitals in the United States that are not explicitly estimat-
ing patients’ periprocedural risks and implementing tailored
risk reduction strategies. Second, we did not have longitudinal
follow-up data for our PCI population, thus precluding longer-
term assessments of potential complications. Third, it is
possible that there are other procedural decisions being made
on the basis of characteristics not captured in this study.
Fourth, costs were obtained from a hospital perspective and
do not capture a broader patient and societal perspective.
Fifth, patient satisfaction was not ascertained formally via
validated scales nor was it available in all the patients given
the limitations of implementation research; it cannot be
concluded that patient satisfaction differed by SDD groups.
Nonetheless, the fact that nearly all the patients reported
excellent patient satisfaction is indicative of the overall signal
in the SDD population and is worth reporting. Sixth, although
a pattern of reduced adverse outcomes in the SDD group
compared with the NSDD group was consistently observed
(Table 2), the rarity of the adverse events limits our statistical
power to investigate the direct impact of SDD on these
outcomes. Larger studies focused primarily on improved
outcomes are needed before the results of this study can be
generalized. Last, it is conceivable that the higher predicted
probabilities of mortality and AKI in the SDD group are
reﬂective of a more cautious and proactive probing during the
latter part of the study (after SDD implementation began).
However, these seemingly paradoxical ﬁndings imply that
when appropriate risk-mitigating measures are undertaken,
SDD can be successfully advised even in the face of a higher
estimated preprocedural risk of a potential negative outcome.
However, when patients were being prepared for SDD after
successful risk mitigation and were doing well clinically after
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PCI, in the absence of symptoms postprocedure, laboratory
tests were not drawn to a greater degree than in NSDD
patients. These missed laboratory tests may have led to an
ascertainment bias favoring SDD for outcomes, such as AKI
and post-PCI myocardial infarction.
Conclusions
We used a novel patient-centered approach to estimate and
mitigate risk as a foundation for facilitating SDD in an
elective, all-comer, PCI population. We observed that SDD
rapidly increased and allowed the discharge of nearly 3 of 4
patients undergoing elective PCI on the same day, despite
complex lesions and comorbid conditions and including
radial or femoral arterial access. Using this approach, we
found that adjusted hospital costs were lower by $7331/
case, favoring SDD. Our study identiﬁes an important
opportunity to improve PCI outcomes and lower hospital
costs with patient-centered decision making. Further well-
controlled observational and interventional studies are
needed to conﬁrm our ﬁndings.
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